ImmunoPrecise Antibodies (IPA) has released an update.
ImmunoPrecise Antibodies Ltd., a company specializing in biotherapeutic research and technology, will be attending and participating in one-on-one meetings at H.C. Wainwright’s 26th Annual Global Investment Conference in New York. This event is an important networking opportunity that brings together professionals from various sectors, including biotech and life sciences. The conference will take place both in-person and virtually from September 9 to 11, 2024.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
